News L&K Biomed Ltd.

Equities

A156100

KR7156100000

End-of-day quote Korea S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
9,980 ^KRW	-2.16%		+8.01%	-1.96%

05-09	L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from a group of investors	CI
05-07	L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from a group of investors	05-08	CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors	05-06	CI
RootLoc Co., Ltd. announced that it has received KRW 3.686515722 billion in funding from L&K Biomed Ltd.	10/09/23	CI
RootLoc Co., Ltd. announced that it expects to receive KRW 3.686515722 billion in funding from L&K Biomed Ltd.	31/08/23	CI
L&K Biomed to Raise 36.6 Billion Won via Shares Issuance; Shares Plunge 23%	15/05/23	MT
L&K Biomed Ltd.(KOSDAQ:A156100) added to S&P Global BMI Index	20/09/21	CI
L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors	15/07/21	CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors	14/07/21	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
L&K Biomed Ltd.'s Equity Buyback announced on May 30, 2017, has expired with 361,567 shares, representing 3.88% for KRW 2,986.18 million.	10/09/20	CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2020.	28/11/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	29/06/19	CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2019.	30/05/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	30/03/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	04/03/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	04/03/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News L&K Biomed Ltd.

Equities

A156100

KR7156100000

Summary

Filters